Aisling Capital Iii Lp

Affiliations

  • Large Shareholder at Loxo Oncology Inc. (LOXO), 2018-07-12
  • Large Shareholder at Syros Pharmaceuticals Inc. (SYRS), 2016-07-06
  • Large Shareholder at Agile Therapeutics Inc (AGRX), 2016-06-03
  • Other at Transenterix Inc. (TRXC), 2016-02-05
  • Large Shareholder at T2 Biosystems Inc. (TTOO), 2015-12-09
  • Large Shareholder at Versartis Inc. (VSAR), 2015-01-29
  • Large Shareholder at Durata Therapeutics Inc. (DRTX), 2014-05-22
  • Large Shareholder at Zeltiq Aesthetics Inc (ZLTQ), 2014-01-27
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
LOXO $31.00 160,000 Large Shareholder 4,188,920 2017-01-10 Filing
SYRS $12.50 400,000 Large Shareholder 908,565 2016-07-06 Filing
LOXO $21.50 232,558 Large Shareholder 4,028,920 2016-05-17 Filing
LOXO $27.50 200 Large Shareholder 3,796,362 2015-12-11 Filing
TTOO $9.75 307,692 Large Shareholder 2,830,992 2015-12-09 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
LOXO $179.43 1,400,000 Large Shareholder 2,038,920 2018-07-10 Filing
LOXO $80.50 250,000 Large Shareholder 3,438,920 2017-12-19 Filing
LOXO $75.00 500,000 Large Shareholder 3,688,920 2017-11-22 Filing
DRTX $15.57 2,649 Large Shareholder 3,030,175 2014-03-21 Filing
DRTX $15.74 98,000 Large Shareholder 3,032,824 2014-03-20 Filing